Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold 0 02.05.2024 13:35 CNBC The company reiterated its full-year 2024 sales guidance of roughly $4 billion, which includes revenue from the expected launch of its RSV vaccine. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
